Aytu Biopharma (AYTU) Interest Coverage Ratio Growth (3y) (2014 - 2023)
Powered by 
Analysis
Aytu Biopharma (AYTU) Interest Coverage Ratio Growth (3y) (2014 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | -1.75% |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -7.51% |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | -26.54% |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 59.44% |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 75.30% |
| 10 | Aytu Biopharma | 22.49 Mn | -4.22 Mn | 7.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 47.73% |
| Sep 30, 2020 | 41.03% |
| Jun 30, 2020 | -14.63% |
| Mar 31, 2020 | 47.13% |
| Dec 31, 2019 | -0.90% |
| Sep 30, 2019 | -19.05% |
| Jun 30, 2019 | -38.89% |
| Mar 31, 2019 | -203.20% |
| Dec 31, 2018 | -41.67% |
| Sep 30, 2018 | -32.70% |
| Jun 30, 2018 | 65.50% |
| Dec 31, 2017 | 21.63% |
| Sep 30, 2017 | 25.62% |
| Feb 28, 2015 | -34.73% |
| May 31, 2014 | 17.69% |
| Feb 28, 2014 | 37.08% |